Artificial Intelligence (AI) in Healthcare Market: Analysis 2024-2032

As per Triton Market Research, the Global Artificial Intelligence (AI) in Healthcare Market report is segmented by Solution (Services, Hardware, Software), Technology (Context Aware Processing, Natural Language Processing, Deep Learning, Querying Method), Industry Vertical (Pharmaceutical and Biotechnology Companies, ACOS and MCOS, Healthcare Providers, Patients, Payers), Type (Administrative Workflow Assistance, Robot-assisted Surgery, Fraud Detection, Clinical Trial Participant Identifier, Virtual Nursing Assistant, Preliminary Diagnosis, Dosage Error Reduction, Other Types), and Regional Outlook (North America, Europe, Middle East and Africa, Asia-Pacific, Latin America).

The report highlights the Market Summary, Industry Outlook, Porter’s Five Forces Analysis, Market Maturity Analysis, Value Chain Analysis, Key Buying Criteria, Regulatory Framework, Key Market Strategies, Market Drivers, Challenges, Opportunities, Analyst Perspective, Competitive Landscape, Research Methodology and scope, Global Market Size, Forecasts & Analysis (2024-2032).

Based on Triton’s research report analysis, the global artificial intelligence (AI) in healthcare market is set to progress at a CAGR of 37.14% during the forecast period 2024-2032.

AI in healthcare employs software and algorithms to mimic human perception, analyzing intricate medical data and the correlation between treatment/prevention methods and patient outcomes.

Factors such as the adoption of AI being supported by large volumes of data, increasing start-ups in AI, and government support fuel the expansion of AI in healthcare market. Biomedical and healthcare information extensively utilizes big data technologies, given the immense volume of biological and clinical data sourced from laboratories and medical research centers. This patient data requires AI-driven analysis to unveil innovative approaches for enhancing healthcare standards. Examples include advanced sequencing machines, novel software and hardware for parallel computing, and the integration of electronic health records (EHR) for comprehensive documentation of patient data.

However, cost constraints and low ROI, challenges in sustaining data security, and slow adoption of AI-based technologies restrict the overall development of the studied market. 

Globally, Asia-Pacific is estimated to emerge as the fastest-growing region during the forecast market. Investments from governments, private organizations, and startups are driving growth in the region’s market. In the region, AI is primarily utilized in areas such as precision medicine and genome testing within the healthcare industry. Hence, advancements in artificial intelligence technology are accelerating the market’s growth across the region. 

The notable companies in the AI in healthcare market are Siemens Healthineers AG, General Vision Inc, IBM Corporation, Koninklijke Philips NV, GE Healthcare, Microsoft Corporation, Google LLC, Intel Corporation, Medtronic Plc, NVIDIA Corporation, Oncora Medical, Recursion Pharmaceuticals Inc, and Stryker Corporation.

During the forecast period, buyers are expected to wield considerable bargaining power in the market. Google, Microsoft, GE Healthcare, IBM, and Intel are the leading revenue generators in this domain, indicating their dominance. Despite this, the market is diverse, comprising various players from regional to international levels. Currently, buyers exhibit moderate bargaining power due to factors such as high switching costs and brand loyalty.